As Africa’s first oral Covid vaccine clinical trial prepares for take-off this month in South Africa, Oramed Pharmaceuticals disclosed it will not be using Pfizer or Johnson & Johnson (J&J).
Ivermectin sales on the black market are on the increase while the South African Health Products Regulatory Authority and the Western Cape Department of Health has warned against the back door sales.
Daily Maverick 168 weekly newspaper.
As the South African Health Products Regulatory Authority (Sahpra) settled several court applications on Tuesday 6 April to provide wider access to ivermectin for the treatment of Covid-19, the country’s infectious disease specialists insisted that this was not the right way to do it.
Despite battling through two brutal waves of the Covid-19 pandemic, South Africa’s frontline doctors, all infectious disease specialists, were among a group of esteemed medical experts who told the court that it was not in the public interest to allow broad access to ivermectin through legal action, insisting that evidence of the drug’s efficacy and safety were still lacking.